The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
Single estrogen receptor (ER)+ and progesterone receptor (PR)+ tumors account for about10% of all breast cancers. However, the prognosis of these single hormone receptor-positive (HR+) tumor remains unclear. We aimed to investigate the characteristics of single HR+ breast tumors according to HER2 st...
Main Authors: | Hengqiang Zhao, Yiping Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.643956/full |
Similar Items
-
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status—A Pilot Study
by: Michał Kunc, et al.
Published: (2020-08-01) -
Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01) -
Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer
by: Iveta Kolarova, et al.
Published: (2019-12-01) -
Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
by: M. Ángeles López-García, et al.
Published: (2020-06-01) -
Comparison of hormonal receptor and HER2 status between ultrasound-guided 14-gauge core needle biopsy and surgery in breast cancer patients
by: Yun Joo Park, et al.
Published: (2014-07-01)